Literature DB >> 9468539

Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1.

S A Wegner1, P K Ehrenberg, G Chang, D E Dayhoff, A L Sleeker, N L Michael.   

Abstract

CXCR4 is both a chemokine receptor and entry co-receptor for T-cell line-adapted human immunodeficiency virus type 1. The genomic organization and promoter function for the entire transcription unit of CXCR4 were determined. The gene contains 2 exons of 103 and 1563 base pairs (bp) interrupted by a 2132-bp intron precisely between codons 5 and 6 of the coding sequences. A transcription start site was identified 88 bp upstream of the initiation codon, and a polyadenylate addition site was identified 22 bp 3' to a polyadenylation signal. Transient expression assays defined a minimal promoter at positions -114 to +43 relative to the transcription start site. This region contains a TATA box, a nuclear respiratory factor-1 (NRF-1) site, and two GC boxes. Specific factor binding to the NRF-1 site and GC boxes were demonstrated by gel mobility shifts and DNase I footprinting. Site-directed mutagenesis showed that the NRF-1 site is crucial for promoter activity providing the first evidence for the regulation of a signal transduction gene by NRF-1. Sequences between -691 and -191 repress CXCR4 promoter activity. Further study of these regulatory elements will be important to understanding how CXCR4 functions as both a chemokine receptor and human immunodeficiency virus type 1 entry co-receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468539     DOI: 10.1074/jbc.273.8.4754

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Targeting lung cancer using an infectivity enhanced CXCR4-CRAd.

Authors:  Zeng B Zhu; Angel A Rivera; Sharmila K Makhija; Baogen Lu; Minghui Wang; Miiru Izumi; Robert J Cerfolio; Mariam A Stoff-Khalili; Fen Zhou; Koichi Takayama; Gene P Siegal; David T Curiel
Journal:  Lung Cancer       Date:  2006-11-17       Impact factor: 5.705

Review 2.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

3.  Enhanced migration and CXCR4 over-expression in fibroblasts with telomerase reconstitution.

Authors:  Yi Qu; Meng Mao; Xihong Li; Lin Zhang; Xiang Huang; Chunlei Yang; Fengyang Zhao; Ying Xiong; Dezhi Mu
Journal:  Mol Cell Biochem       Date:  2008-03-25       Impact factor: 3.396

4.  Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer.

Authors:  Xiuyun Jiang; Kevin M Sullivan; Yongwoo David Seo; Florencia G Jalikis; Kimberly S Smythe; Arezou Abbasi; Marissa Vignali; James O Park; Sara K Daniel; Seth M Pollack; Teresa S Kim; Raymond Yeung; Ian Nicholas Crispe; Robert H Pierce; Harlan Robins; Venu G Pillarisetty
Journal:  Clin Cancer Res       Date:  2019-04-02       Impact factor: 12.531

Review 5.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

6.  Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population.

Authors:  Desiree C Petersen; Richard H Glashoff; Sadeep Shrestha; Julie Bergeron; Annette Laten; Bert Gold; Estrelita Janse van Rensburg; Michael Dean; Vanessa M Hayes
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-15       Impact factor: 3.731

7.  The US27 gene product of human cytomegalovirus enhances signaling of host chemokine receptor CXCR4.

Authors:  Kathleen L Arnolds; Angela P Lares; Juliet V Spencer
Journal:  Virology       Date:  2013-03-13       Impact factor: 3.616

8.  The NRF-1/alpha-PAL transcription factor regulates human E2F6 promoter activity.

Authors:  Zoulika Kherrouche; Yvan De Launoit; Didier Monte
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

Review 9.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

10.  The Role of chemokine receptor CXCR4 in breast cancer metastasis.

Authors:  Debarati Mukherjee; Jihe Zhao
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.